PE anti-human HLA-A2 Antibody
- 产品名称：
- PE anti-human HLA-A2 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 343305
- 产品应用：
- 343305
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1548 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Papain solubilized HLA-A2
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
The BB7.2 antibody recognizes human leukocyte antigen (HLA) A2 which is a subset of MHC-class I molecules encoded by A*02 alleles.
Additional reported applications (for the relevant formats) include: immunoprecipitation3.
- Application References
(PubMed link indicates BioLegend citation) -
- Brodsky FM, et al. 1979. Immunol. Rev. 47:3.
- Parham P and Brodsky FM. et al. 1981. Hum. Immunol. 3:277.
- Lubben NB, et al. 2007. Mol Biol Cell. 18:3351. (IP)
- Product Citations
-
- Ameres S, et al. 2014. J Immunol. 192:5894. PubMed
- Schuler P, et al. 2014. Clin Cancer Res. 20:2433. PubMed
- Gu C, et al. 2019. J Immunol. 203:389. PubMed
- Xiao C, et al. 2022. iScience. 25:103934. PubMed
- Wang X, et al. 2011. Blood. 117:1888. PubMed
- Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
- Pellegrini JM, et al. 2021. Sci Rep. 11:13559. PubMed
- Klatt MG, et al. 2020. J Proteomics. 228:103921. PubMed
- Abdelaziz MO, et al. 2019. Front Immunol. 1.65. PubMed
- Lai J, et al. 2016. Blood. 128: 1396 - 1407. PubMed
- Barili V, et al. 2020. Nat Commun. 0.877777778. PubMed
- Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
- FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
- Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
- G?rtner K, et al. 2019. J Extracell Vesicles. 8:1573051. PubMed
- Pettmann J, et al. 2021. eLife. 10:00. PubMed
- RRID
- AB_1877228 (BioLegend Cat. No. 343305) AB_1877227 (BioLegend Cat. No. 343306)
